Symbol Lookup

Tuesday April 28, 2015 2:13 PM ET. Data delayed 15 minutes.
1.90
0.00 (0.00%)
Bid/Lots
1.88/7
Ask/Lots
1.92/9
Open/Prev Close
1.90/1.90
Day Range
1.85-1.92
52-Week Range
1.09-2.88
Vol/Avg Daily Vol
27.7K/43.1K
  • TSX Comp
  • TSX Venture
  • DJIA
  • S&P 500
  • NASDAQ
Price Comparison Chart
Data delayed at least 15 minutes.

Recent News»

0 New Today
CombiMatrix Executes Final Settlement Ending Litigation
6 hours ago by GlobeNewswire

CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre-implantation genetic screening (PGS), pre- and postnatal developmental disorders, today announced the execution of a Settl...

CombiMatrix Launches Buccal Swab DNA Collection as Alternative to Blood Draws for Postnatal Genetic Testing
8:05AM ET on Thursday Apr 16, 2015 by GlobeNewswire

CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based diagnostic services for prenatal, postnatal, and pre-implantation genetic testing today announced the availability of its new Buccal Swab DNA Colle...

Stocks Eye Near Unchanged Open as GE Leads Gainers
9:11AM ET on Friday Apr 10, 2015 by Midnight Trader
09:11 AM EDT, 04/10/2015 (MT Newswires) -- U.S. stocks were poised to open nearly unchanged, with the S&P 500 and the Dow barely higher and the Nasdaq flat, with little news or economic data to drive sentiment except for General Electric's (GE) p...
CombiMatrix Climbs Pre-Bell as Article Supports Follow-Up Diagnostic Testing After Positive Noninvasive Prenatal Screening
8:25AM ET on Friday Apr 10, 2015 by Midnight Trader
08:25 AM EDT, 04/10/2015 (MT Newswires) -- CombiMatrix (CBMX) shares jumped in Friday's pre-market session after the molecular-diagnostics company specializing in DNA-based diagnostic services for prenatal, postnatal and pre-implantation genetic ...
New England Journal of Medicine Article Supports Importance of Follow-up Diagnostic Testing Following Positive Noninvasive Prenatal Screening Test
8:00AM ET on Friday Apr 10, 2015 by GlobeNewswire

CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based diagnostic services for prenatal, postnatal, and pre-implantation genetic testing today announced that an article and a letter to the editor publis...

Company Information

CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary, CombiMatrix Molecular Diagnostics, Inc. located in Irvine, California. The Company operates as a diagnostics reference laboratory, providing DNA-based clinical diagnostic testing services to physicians, hospitals, clinics and other laboratories in the areas of pre-and postnatal development disorders and hematology/oncology genomics. The Company's oligo arrays allow the Company to perform aCGH on a much more refined scale than is possible with BAC technology.

CONTACT INFORMATION

Headquarters310 Goddard Ste 150
IRVINE, CA, United States 92618-4617
Phone949-753-0624
Fax949-753-4725

EXECUTIVE OFFICERS

Chairman of the BoardRobert Jessup
President, Chief Executive Officer, DirectorMark McDonough
Chief Financial Officer, Treasurer, SecretaryScott Burell
DirectorLale White
Independent DirectorScott Gottlieb

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Stocks Ratings Sample

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

  •  
  • INK Company Insider

    Detailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®

  • S&P Capital IQ Stock Report

    S&P Capital IQ's analysts' overview and valuation, with key fundamental, quantitative, and technical analysis.

  • TDSI Morning Action Notes

    Morning Institutional Report of company updates and new recommendations.

Market Cap$24.1MBeta0.15
Revenue (TTM)$8.0MEPS$-0.79
Shares Out.12.7MBook Value$0.64
Dividend Yield0.00%P/E--
Annual Dividend Rate0.00 USDPrice/Sales (TTM)3.0
Ex-Div Date1/1/01P/Cash Flow (TTM)--
Pay Date1/1/01Operating Margin-108.85%

*GAAP = prior to non-GAAP analyst adjusted earnings.

(Non-GAAP)*

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Stocks Calendar Sample